Used primarily as a pharmaceutical intermediate in the synthesis of Toll-like receptor (TLR) agonists, particularly TLR7 and TLR8. These agonists play a key role in immunomodulatory therapies, including the development of treatments for viral infections, cancer, and vaccine adjuvants. The compound’s structure supports potent immune activation by mimicking pathogen-associated molecular patterns, making it valuable in research and development of novel immunotherapeutics.